STUDI PENGGUNAAN ANTIRETROVIRAL PADA PASIEN HIV/AIDS (Penelitian dilaksanakan di Instalasi Rawat Jalan Rumah Sakit Universitas Airlangga Surabaya)
Human Immunodeficiency Virus is a retrovirus that causes a decrease in human immune system which could lead to the occurrence of AIDS (Acquired Immunodeficiency Syndrome). This study aimed to describe the pattern of antiretroviral use in HIV/AIDS outpatient. This study was a retrospective study...
Saved in:
| Main Author: | |
|---|---|
| Format: | Theses and Dissertations NonPeerReviewed |
| Language: | English English English Indonesian |
| Published: |
2019
|
| Subjects: | |
| Online Access: | http://repository.unair.ac.id/91177/1/FF.FK.61-19%20Pin%20s%20abtsrak.pdf http://repository.unair.ac.id/91177/2/FF.FK.61-19%20Pin%20s%20daftar%20isi.pdf http://repository.unair.ac.id/91177/3/FF.FK.61-19%20Pin%20s%20daftar%20pustaka.pdf http://repository.unair.ac.id/91177/4/FF.FK.61-19%20Pin%20s.pdf http://repository.unair.ac.id/91177/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universitas Airlangga |
| Language: | English English English Indonesian |
| Summary: | Human Immunodeficiency Virus is a retrovirus that causes a
decrease in human immune system which could lead to the occurrence of
AIDS (Acquired Immunodeficiency Syndrome). This study aimed to
describe the pattern of antiretroviral use in HIV/AIDS outpatient. This study
was a retrospective study with a total sampling method. Data were retrieved
from the medical records of patients who diagnosed with HIV/AIDS and
fulfilled the inclusion criteria, aged ≥18 years old and using firstline
antiretroviral therapy (ART), from January 2nd till December 31st , 2018 in
the outpatient care unit at the Universitas Airlangga Hospital Surabaya.
There were 73 patients included in the study and of which 67,1% were
male. The most use widely ARV regimen in this study were tenofovir
(TDF) 300mg, lamivudine (3TC) 300mg and efavirenz (EFZ) 600mg. Drugrelated-
problems identified in this study were potential drug-drug
interactions of nevirapine and rifampicin, zidovudine and fluconazole,
zidovudine and rifampicin, efavirenz and rifampicin. Moreover the actual
side effects that identified were anemia, increased hepatic transaminases,
nausea, and headache. It guidelines a prospective study could be conducted
to obtain outcome data from the long term use of antiretroviral in
HIV/AIDS outpatient. |
|---|